subject: Aarkstore Enterprise Myrexis Inc Product Pipeline Review Q4 2010 [print this page] Aarkstore announce a new report "Myrexis Inc Product Pipeline Review Q4 2010" through its vast collection of market research report.
Myrexis Inc - Product Pipeline Review - Q4 2010 provides data on the companys research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from proprietary databases, Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together.
Scope
- Myrexis Inc - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Myrexis Inc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Myrexis Inc with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Myrexis Incs pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Myrexis Incs strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Myrexis Inc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Myrexis Incs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Myrexis Inc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Myrexis Inc and identify potential opportunities in those areas.
